Skip to main content
Top
Published in: Drug Safety 6/2009

01-06-2009 | Leading Article

Potential Risks Associated with the Use of Herbal Anti-Obesity Products

Author: Professor Thomas Y. K. Chan

Published in: Drug Safety | Issue 6/2009

Login to get access

Abstract

The public wants an easy way to control obesity. Herbal anti-obesity products attract users because of their health claims, assumed safety, easy availability and extensive marketing. These products can be very heterogeneous in nature and have unpredictable levels of active ingredients, and unpredictable and potentially harmful effects. They may contain highly toxic herbs (e.g. Aristolochia species), potent herbs not recommended for use in weight control (e.g. Ephedra sinica) and herbal laxatives with potential hepatotoxic and nephrotoxic effects (e.g. anthraquinones). However, the presence of such herbs may not be disclosed on the product label. They may contain adulterants (e.g. drugs, drug analogues and thyroid extracts), including drugs that have been withdrawn from the market (e.g. fenfluramine). For all these reasons, herbal anti-obesity products can cause direct toxicity or adverse interactions with concurrent medications. Physicians and other healthcare professionals need to be aware of the problem. They should warn their patients about the heterogeneous nature of these agents and the potential risks associated with their use. They should report suspected adverse reactions to their national spontaneous reporting system.
Literature
1.
go back to reference Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35: 93–9PubMedCrossRef Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35: 93–9PubMedCrossRef
2.
go back to reference Sharpe PA, Granner ML, Conway JM, et al. Availability of weight-loss supplements: results of an audit of retail outlets in a southeastern city. J Am Diet Assoc 2006; 106: 2045–51PubMedCrossRef Sharpe PA, Granner ML, Conway JM, et al. Availability of weight-loss supplements: results of an audit of retail outlets in a southeastern city. J Am Diet Assoc 2006; 106: 2045–51PubMedCrossRef
3.
go back to reference Blanck HM, Serdula MK, Gillespie C, et al. Use of non-prescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc 2007; 107: 441–7PubMedCrossRef Blanck HM, Serdula MK, Gillespie C, et al. Use of non-prescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc 2007; 107: 441–7PubMedCrossRef
4.
5.
go back to reference Pittler MH, Schmidt K, Ernst E. Adverse events of herbal food supplements for body weight reduction: systematic review. Obesity Rev 2005; 6: 93–111CrossRef Pittler MH, Schmidt K, Ernst E. Adverse events of herbal food supplements for body weight reduction: systematic review. Obesity Rev 2005; 6: 93–111CrossRef
6.
go back to reference Chitturi S, Farrell GC. Hepatotoxic slimming aids and other herbal hepatotoxins. J Gastroenterol Hepatol 2008; 23: 366–73PubMedCrossRef Chitturi S, Farrell GC. Hepatotoxic slimming aids and other herbal hepatotoxins. J Gastroenterol Hepatol 2008; 23: 366–73PubMedCrossRef
7.
go back to reference National Heart, Lung, and Blood Institute and North American Association for the Study of Obesity. NHLBI obesity education initiative: practical guide to the identification, evaluation and treatment of overweight and obesity in adults. Bethesda (MD): National Institutes of Health, 2000. NIH publication number 98–4084 National Heart, Lung, and Blood Institute and North American Association for the Study of Obesity. NHLBI obesity education initiative: practical guide to the identification, evaluation and treatment of overweight and obesity in adults. Bethesda (MD): National Institutes of Health, 2000. NIH publication number 98–4084
9.
go back to reference Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002; 17: 265–77PubMedCrossRef Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002; 17: 265–77PubMedCrossRef
10.
go back to reference Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008; 74: 158–69PubMedCrossRef Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008; 74: 158–69PubMedCrossRef
11.
go back to reference Wong A, Chan C. Review of adverse events related to Chinese medicines in Hong Kong, July 2004–June 2005. Public Health Epidemiol Bull 2005; 14: 45–51 Wong A, Chan C. Review of adverse events related to Chinese medicines in Hong Kong, July 2004–June 2005. Public Health Epidemiol Bull 2005; 14: 45–51
12.
go back to reference Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387–91PubMedCrossRef Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993; 341: 387–91PubMedCrossRef
13.
go back to reference Wen YJ, Su T, Tang JW, et al. Cytotoxicity of phenanthrenes extracted from Aristolochia contorta in human proximal tubular epithelial cell line. Nephron Exp Nephrol 2006; 103: e95–102PubMedCrossRef Wen YJ, Su T, Tang JW, et al. Cytotoxicity of phenanthrenes extracted from Aristolochia contorta in human proximal tubular epithelial cell line. Nephron Exp Nephrol 2006; 103: e95–102PubMedCrossRef
14.
go back to reference Ioset J-R, Raoelison GE, Hostettmann K. Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. Food Chem Toxicol 2003; 41: 29–36PubMedCrossRef Ioset J-R, Raoelison GE, Hostettmann K. Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. Food Chem Toxicol 2003; 41: 29–36PubMedCrossRef
15.
go back to reference Gold LS, Slone TH. Aristolochic acid, an herbal carcinogen, sold on the web after FDA alert [letter]. N Engl J Med 2003; 349: 1576–7PubMedCrossRef Gold LS, Slone TH. Aristolochic acid, an herbal carcinogen, sold on the web after FDA alert [letter]. N Engl J Med 2003; 349: 1576–7PubMedCrossRef
16.
go back to reference Martena MJ, van der Wielen JC, van de Laak LF, et al. Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market. Anal Bioanal Chem 2007; 389: 263–75PubMedCrossRef Martena MJ, van der Wielen JC, van de Laak LF, et al. Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market. Anal Bioanal Chem 2007; 389: 263–75PubMedCrossRef
17.
go back to reference Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343: 1833–8PubMedCrossRef Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343: 1833–8PubMedCrossRef
18.
go back to reference Maglione M, Miotto K, Iguchi M, et al. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events. Am J Psychiatr 2005; 162: 189–91PubMedCrossRef Maglione M, Miotto K, Iguchi M, et al. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events. Am J Psychiatr 2005; 162: 189–91PubMedCrossRef
19.
go back to reference Li FK, Lai CK, Poon WT, et al. Aggravation of non-steroidal anti-inflammatory drug-induced hepatitis and acute renal failure by slimming drug containing anthra-quinones. Nephrol Dial Transplant 2004; 19: 1916–7PubMedCrossRef Li FK, Lai CK, Poon WT, et al. Aggravation of non-steroidal anti-inflammatory drug-induced hepatitis and acute renal failure by slimming drug containing anthra-quinones. Nephrol Dial Transplant 2004; 19: 1916–7PubMedCrossRef
20.
go back to reference Kwan TH, Tong MK, Leung KT, et al. Acute renal failure associated with prolonged intake of slimming pills containing anthraquines. Hong Kong Med J 2006; 12: 394–7PubMed Kwan TH, Tong MK, Leung KT, et al. Acute renal failure associated with prolonged intake of slimming pills containing anthraquines. Hong Kong Med J 2006; 12: 394–7PubMed
21.
go back to reference Yuen MF, Tam S, Fung J, et al. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment Pharmacol Ther 2006; 24: 1179–86PubMedCrossRef Yuen MF, Tam S, Fung J, et al. Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1-year prospective study. Aliment Pharmacol Ther 2006; 24: 1179–86PubMedCrossRef
22.
go back to reference van Gorkom BA, de Vries EG, Karrenbeld A, et al. Anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther 1999; 13: 443–52PubMedCrossRef van Gorkom BA, de Vries EG, Karrenbeld A, et al. Anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther 1999; 13: 443–52PubMedCrossRef
23.
go back to reference Hong Kong Consumer Council. A detailed analysis on proprietary cleansing and slimming products. Choice Mag 2001; 301: 12–23 Hong Kong Consumer Council. A detailed analysis on proprietary cleansing and slimming products. Choice Mag 2001; 301: 12–23
25.
go back to reference Keisler BD, Hosey RG. Ergogenic aids: an update on ephedra. Curr Sports Med Rep 2005; 4: 231–5PubMed Keisler BD, Hosey RG. Ergogenic aids: an update on ephedra. Curr Sports Med Rep 2005; 4: 231–5PubMed
26.
go back to reference Podrid PJ. Proarrhythmia, a serious complication of anti-arrhythmic drugs. Curr Cardiol Rep 1999; 1: 289–96PubMedCrossRef Podrid PJ. Proarrhythmia, a serious complication of anti-arrhythmic drugs. Curr Cardiol Rep 1999; 1: 289–96PubMedCrossRef
27.
28.
go back to reference Wang J, Chen B, Yao S. Analysis of six synthetic adulterants in herbal weight-reducing dietary supplements by LC electro-spray ionization-MS. Food Addit Contam 2008; 25: 822–30CrossRef Wang J, Chen B, Yao S. Analysis of six synthetic adulterants in herbal weight-reducing dietary supplements by LC electro-spray ionization-MS. Food Addit Contam 2008; 25: 822–30CrossRef
29.
go back to reference Metcalfe K, Corns C, Fahie-Wilson M, et al. Chinese medicines for slimming still cause health problems [letter]. BMJ 2002; 324: 679PubMedCrossRef Metcalfe K, Corns C, Fahie-Wilson M, et al. Chinese medicines for slimming still cause health problems [letter]. BMJ 2002; 324: 679PubMedCrossRef
30.
go back to reference Chang K, Mak TWL, Kwong L, et al. Valvular heart disease caused by Chinese proprietary slimming medicine adulterated with fenfluramine. Hong Kong J Paediatr 2005; 10: 55–8 Chang K, Mak TWL, Kwong L, et al. Valvular heart disease caused by Chinese proprietary slimming medicine adulterated with fenfluramine. Hong Kong J Paediatr 2005; 10: 55–8
31.
go back to reference Dunnick JK, Hailey JR. Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer Res 1996; 56: 4922–6PubMed Dunnick JK, Hailey JR. Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer Res 1996; 56: 4922–6PubMed
32.
go back to reference Nakadai A, Inagaki H, Minami M, et al. Determination of the optical purity of N-nitrosofenfluramine found in the Chinese slimming diet. Yakugaku Zasshi 2003; 123: 805–9PubMedCrossRef Nakadai A, Inagaki H, Minami M, et al. Determination of the optical purity of N-nitrosofenfluramine found in the Chinese slimming diet. Yakugaku Zasshi 2003; 123: 805–9PubMedCrossRef
33.
go back to reference Adachi M, Saito H, Kobayashi H, et al. Hepatic injury in 12 patients taking the herbal weight loss aids Chaso or Onshido. Ann Intern Med 2003; 139: 488–92PubMed Adachi M, Saito H, Kobayashi H, et al. Hepatic injury in 12 patients taking the herbal weight loss aids Chaso or Onshido. Ann Intern Med 2003; 139: 488–92PubMed
34.
go back to reference Ohye H, Fukata S, Kanoh M, et al. Thyrotoxicosis caused by weight-reducting herbal medicines. Arch Intern Med 2005; 165: 831–4PubMedCrossRef Ohye H, Fukata S, Kanoh M, et al. Thyrotoxicosis caused by weight-reducting herbal medicines. Arch Intern Med 2005; 165: 831–4PubMedCrossRef
35.
go back to reference Poon WT, Ng SW, Lai CK, et al. Factitious thyrotoxicosis and herbal dietary supplement for weight reduction. Clin Toxicol 2008; 46: 290–2CrossRef Poon WT, Ng SW, Lai CK, et al. Factitious thyrotoxicosis and herbal dietary supplement for weight reduction. Clin Toxicol 2008; 46: 290–2CrossRef
36.
go back to reference Anonymous. Thyroid extracts as slimming aids: danger! [editorial]. Prescrire Int 2006; 15: 183 Anonymous. Thyroid extracts as slimming aids: danger! [editorial]. Prescrire Int 2006; 15: 183
Metadata
Title
Potential Risks Associated with the Use of Herbal Anti-Obesity Products
Author
Professor Thomas Y. K. Chan
Publication date
01-06-2009
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 6/2009
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200932060-00002

Other articles of this Issue 6/2009

Drug Safety 6/2009 Go to the issue